Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Net Margin Over TimeContracting
Percentile Rank64
3Y CAGR-9.5%
5Y CAGR-14.0%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
-9.5%/yr
Annual compound
5Y CAGR
-14.0%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM22.69%-48.1%
202443.74%+28.8%
202333.96%+10.9%
202230.62%-66.3%
202190.84%+88.3%
202048.24%+230.9%
2019-36.86%+30.3%
2018-52.90%-366.0%
201719.89%+128.3%
2016-70.23%-